Quotables
"There is no likelihood man can ever tap the power of the atom."
Robert Millikan, Nobel Prize winner in physics
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7427600 | Active agent delivery systems and methods for protecting and administering active agents The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions... | 09/23/2008 |
| 7326809 | Salts of 4- or 5-aminosalicylic acid The present invention provides L-arginine salts of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these L-arginine salts of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of an inflammatory condition of the GI t... | 02/05/2008 |
| 7138538 | Process for the separation of enantiomers and enantiopure reagent Process for the separation of enantiomers comprising at least one free functional group, in which process a reagent based on an enantiopure amino acid is reacted in basic medium with a mixture comprising enantiomers. ... | 11/21/2006 |
| 6903082 | Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof Compounds are disclosed having the structure of Formula I: where R1, R3, and R4 are independently hydrogen or C1 to C4 alkyl, and R2 is: | 06/07/2005 |
| 6743373 | Process for the separation of enantiomers and enantiopure reagent Process for the separation of enantiomers comprising at least one free functional group, in which process a reagent based on an enantiopure amino acid is reacted in basic medium with a mixture comprising enantiometers. ... | 06/01/2004 |
| 6716881 | Carbanilides used as pesticides The present invention provides carbanilides of formula (I), wherein A, Q, R, X, Z and m are as defined herein. A plurality of processes for preparing these compounds is provided, along with methods of using the compounds... | 04/06/2004 |
| 6696606 | Solid phase synthesis of arylretinamides A solid phase synthetic method for preparing arylretinamides is provided. The method comprises reacting hexachloroacetone with a solvent-suspended resin-bound triphenylphosphine to provide a suspension comprising an activated chlorinating reagent; reactin... | 02/24/2004 |
| 6686386 | Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis The present invention relates to pharmaceutical and cosmetic compositions comprising at least one agonist ligand, which is specific for receptors of the RAR-γ type, which are characterized as inducers of apoptosis in at least one cell population in which... | 02/03/2004 |
| 6624153 | Halogenated antituberculosis agents Halogenated derivatives of two synthetic anti-tuberculosis agents, thioacetazone and p-aminosalicylic acid, have been synthesized. In general, the halogenated compound has the structure of Structure I: ##STR1## wherein X1 is a halogen and X | 09/23/2003 |
| 6600069 | Benzene tricarboxylic acid derivatives as insulin receptor activators Compounds of Formula I, and pharmaceutical compositions containing these compounds, activate the insulin receptor kinase, which leads to an increased sensitivity to insulin and an increase in glucose uptake, and are therefore useful for the treatment of a... | 07/29/2003 |
| 6573252 | Medicine nitrate salts The present invention relates to nitrate salts of compounds having therapeutic activity in bony disorders, such compounds being characterized in that they contain at least a reactive group capable of being salified with nitric acid.... | 06/03/2003 |
| 6306840 | Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us... | 10/23/2001 |
| 6137003 | Bis (haloethyl) aminobenzene derivatives The present invention relates to bis(haloethyl)aminobenzene derivatives featured by having carboxyl-containing moiety and one other moiety at the ortho position with respect to the bis(haloethyl)amino substituent of the benzene ring. The moiety at the ort... | 10/24/2000 |
| 6114386 | Inhibitors of bacterial sialidase A sialidase inhibitor of the shown formula I: ##STR1## where dashed lines d1 and d2, X1, R1, R2, R6, R3, R4 and R5 are as described in the specificatio... | 09/05/2000 |
| 5985927 | Medicaments for the selective treatment of tumor tissues Medicinal products for the selective control of tumor tissue and a method for control of such tumor tissue by administration of such product to a host. The products comprise: (a) two different compounds having a pH below 7 when the compounds are present i... | 11/16/1999 |
| 5840966 | Hydroxylation of salicylic acid derivatives The invention disclosed relates to the novel compound 5-amino tetrahydroxy benzoic acid and derivatives thereof, e.g. pharmaceutically acceptable acid addition salts, to a process for the preparation thereof which involves reacting 5-amino salicylic acid ... | 11/24/1998 |
| 5795914 | Phenylalkan(en)oic acid The phenylalkan(en)oic acids of the formula: ##STR1## wherein the substituents are defined in the specification.... | 08/18/1998 |
| 5714517 | Fluoroalkenyl compounds and their use as pest repellents Fluorinated alkene compounds useful for and methods of controlling nematodes, insects, and acarids that prey on agricultural crops. Polar compounds, for example, 3,4,4-trifluoro-3-butene-1-amine or 3,4,4-trifluoro-3-butenoic acid, are particularly useful ... | 02/03/1998 |
| 5668257 | Phenylboronic acid complexing reagents derived from aminolalicylic acid The present invention relates to a novel class of phenylboronic acid complexing reagents useful for the preparation of bioconjugates, and the method of making and using such reagents. In the present invention, in the place of prior art Avidin-Biotin and D... | 09/16/1997 |
| 5661183 | 3-hydroxy anthanilic acid derivatives The present invention relates to novel derivatives of 3-hydroxyanthranilic acid, 3-HANA of general formula (I), wherein R1 and R2 are the same or different and selected from H and alkyl; X is selected from alkylthio, arylthio, arylox... | 08/26/1997 |
| 5631402 | Process for preparing aminobenzoic acid derivatives An aminobenzoic acid derivative represented by the following general formulas (I), (I-2) or (I-3), or a pharmacologically acceptable salt thereof, which exhibits a serotonin antagonism and an acetylcholine release accelerating activity at a well-balanced ... | 05/20/1997 |
| 5629436 | Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress N-arylmethylene ethylenediaminetriacetate, N-arylmethylene iminodiacetate or N,N'-diarylmethylene ethylenediaminediacetate type compounds and their use in combatting oxidative stress, and pharmaceutical and cosmetic compositions comprising said compounds.... | 05/13/1997 |
| 5594151 | Phenylboronic acid complexing reagents derived from aminosalicylic acid The present invention relates to a novel class of phenylboronic acid complexing reagents useful for the preparation of bioconjugates, and the method of making and using such reagents. In the present invention, in the place of prior art Avidin-Biotin and D... | 01/14/1997 |
| 5587505 | Triterpene derivatives and endothelin-receptor antagonists containing the same Triterpene derivatives of the formula (I): ##STR1## wherein R1 is hydrogen or metabolic ester residue; and R2 is hydrogen or --R3 -R4 wherein R3 is --SO3 --, --CH2 COO--, --... | 12/24/1996 |
| 5478835 | Tricyclic compounds and intermediates thereof Disclosed is a tricyclic compound represented by the formula (I): ##STR1## wherein each of R1, R2, R3 and R4 independently represents hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, amino, C1-6 alkylamin... | 12/26/1995 |
| 5476860 | Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics Diaromatic compounds, characterized in that they correspond to the following general formula: ##STR1## in which: R1 is --CH3, --CH2 OH, --COR8 or --CH2 OCOR9, R8 is H, OH, -... | 12/19/1995 |
| 5436367 | Intermediates for certain 4-oxoquinoline-3-carboxylic acid derivatives Compounds of formula (I): ##STR1## (in which: R1 represents fluorinated methoxy; R2 represents a nitrogen-containing heterocyclic group and R3 represents hydrogen or amino) and pharmaceutically acceptable salts, ester... | 07/25/1995 |
| 5389680 | Fluoroalkenyl compounds and their use as pest repellents Fluorinated alkene compounds useful for and methods of controlling nematodes, insects, and acarids that prey on agricultural crops. Polar compounds, for example, 3,4,4-trifluoro-3-butene-1-amine or 3,4,4-trifluoro-3-butenoic acid, are particularly useful ... | 02/14/1995 |
| 5387594 | Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics Di(aromatic) compounds corresponding to the following formula: ##STR1## in which: Ar represents either ##STR2## n=1 or 2 or: ##STR3## X represents a divalent radical, Z represents O, S or a divalent radical, and R1, R2... | 02/07/1995 |
| 5324747 | N-substituted anilines, inhibitors of phospholipases A2 Compounds of the formula ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, n, m, o, p and q are as hereinafter set forth, and, when R2 is hydrogen, phar... | 06/28/1994 |
| 5274002 | Trisubstituted phenyl analogs having activity for congestive heart failure Novel trisubstituted phenyl analogs are now found to have activity as for the treatment of congestive heart failure.... | 12/28/1993 |
| 5247091 | Preparation of enamines in aqueous media The synthesis of enamines in aqueous media and a process for the preparation of memory enhancing 9-amino-1,2,3,4-tetrahydracridines are described.... | 09/21/1993 |
| 5126481 | ଲ-phenoxyethylamines and their use for the preparation of dyestuffs The preparation is described of compounds of the structure ##STR1## in which the substituents have the meanings indicated in the description. The compounds, which are in part new, are used as intermediate products for dyestuffs.... | 06/30/1992 |
| 5105021 | Preparation of a difluorohalomethoxybenzene A higher yield of the difluorohalomethoxybenzene produced by the reaction of a metal phenolate with dibromodifluoromethane or bromochlorodifluoromethane can be obtained by conducting the addition of a metal alcoholate or a metal hydride as a reaction init... | 04/14/1992 |
| 5103037 | Substituted di-t-butylphenols Novel compounds which are 2,6-di-t-butylphenols substituted in the 4 position by a carbamyl or acylamino group, which carbamyl or acylamino group is substituted by a group which includes an acidic substituent are useful as inhibitors of leukotriene biosyn... | 04/07/1992 |
| 5068384 | Phosphate salts of AB-polybenzoxazole monomer AB-polybenzoxazole monomer, such as 3-amino-4-hydroxybenzoic acid, can be synthesized in high yields from a hydroxy-benzoic acid or related compound in a three-step process of (1) nitration, (2) hydrolysis of the ester, and (3) reduction of the nitro moie... | 11/26/1991 |
| 5068392 | Process for the preparation of 2-chloro and 2,6-dichloroanilines 2-Chloro and 2,6-dichloroanilines, optionally substituted in the 3-, 5-, and/or 6-position are prepared from the corresponding anilides by selective bromination, chlorination, reduction and hydrolysis. The selectivity of the process for introducing chlori... | 11/26/1991 |
| 5049572 | Substituted di-t-butylphenols and anti-allergic use thereof Novel compounds which are 2,6-di-t-butylphenols substituted in the 4 position by a carbamyl or acylamino group, which carbamyl or acylamino group is substituted by a group which includes an acidic substituent are useful as inhibitors of leukotriene biosyn... | 09/17/1991 |
| 5047425 | Amine derivatives having cardiovascular activity Compounds of the formula ##STR1## wherein Ar, R, R1, R2, R3, R4, X and n have the meanings mentioned in the description, processes and intermediates for their preparation, pharmaceutical compositions which ... | 09/10/1991 |
| 5041629 | Beta-phenoxyethylamines and their use for the preparation of dyestuffs The preparation is described of compounds of the structure ##STR1## in which the substituents have the meanings indicated in the descripion. The compounds, which are in part new, are used as intermediate products for dyestuffs.... | 08/20/1991 |
